Ocular Therapeutix Inc

NASDAQ:OCUL

12.21

-0.09 (-0.73%)

4:45:04 PM EDT: $12.01 -0.20 (-1.64%)

Market Cap (Intraday)	2.11B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$14.48 Million
Adjusted EPS	-$0.38

See more estimates

10-Day MA	$12.06
50-Day MA	$10.15
200-Day MA	$8.74

See more pivots

Ocular Therapeutix Inc Stock, NASDAQ:OCUL

15 Crosby Drive, 15 Crosby Drive, Bedford, Massachusetts 01730

United States of America

Phone: +1.781.357.4000

Number of Employees: 274

http://www.ocutx.com

Description

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.